Today, PTK6 is a topic that arouses great interest and debate in society. Since its origins, PTK6 has captured the attention of people of all ages, cultures and contexts, becoming a frequent topic of conversation both professionally and personally. Over time, PTK6 has evolved in various ways and has acquired a relevant role in different aspects of daily life. Thus, it is essential to analyze and understand PTK6 in depth, its implications and its impact on today's society. In this article, we will delve into the world of PTK6 to address its many facets and offer a broad and enriching vision of this topic that is so relevant today.
Tyrosine-protein kinase 6 is an enzyme that in humans is encoded by the PTK6gene.[5][6][7]
Function
Tyrosine-protein kinase 6—also known as BRK[7] (breast tumor kinase)—is a cytoplasmic non-receptor protein kinase which may function as an intracellular signal transducer in epithelial tissues. The encoded protein has been shown to undergo autophosphorylation.[7]
Clinical significance
Overexpression of this gene in mammary epithelial cells leads to sensitization of the cells to epidermal growth factor and results in a partially transformed phenotype. Expression of this gene has been detected at low levels in some breast tumors but not in normal breast tissue.[7]
^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Lee ST, Strunk KM, Spritz RA (December 1993). "A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes". Oncogene. 8 (12): 3403–10. PMID8247543.
^Park SH, Lee KH, Kim H, Lee ST (September 1997). "Assignment of the human PTK6 gene encoding a non-receptor protein tyrosine kinase to 20q13.3 by fluorescence in situ hybridization". Cytogenet Cell Genet. 77 (3–4): 271–2. doi:10.1159/000134595. PMID9284935.
Serfas MS, Tyner AL (2003). "Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases". Oncol. Res. 13 (6–10): 409–19. doi:10.3727/096504003108748438. PMID12725532.
Mitchell PJ, Barker KT, Martindale JE, et al. (1994). "Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumours". Oncogene. 9 (8): 2383–90. PMID8036022.
Llor X, Serfas MS, Bie W, et al. (1999). "BRK/Sik expression in the gastrointestinal tract and in colon tumors". Clin. Cancer Res. 5 (7): 1767–77. PMID10430081.
Hong E, Shin J, Bang E, et al. (2001). "Complete sequence-specific 1H, 13C and 15N resonance assignments of the human PTK6 SH2 domain". J. Biomol. NMR. 19 (3): 291–2. doi:10.1023/A:1011221125013. PMID11330822. S2CID20836477.
Kang KN, Kim M, Pae KM, Lee ST (2002). "Characterization of the 5'-flanking region of the human PTK6 gene". Biochim. Biophys. Acta. 1574 (3): 365–9. doi:10.1016/s0167-4781(02)00234-8. PMID11997104.